GLMD (Galmed Pharmaceuticals) Operating Cash Flow per Share : $-19.20 (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Galmed Pharmaceuticals Operating Cash Flow per Share?

Galmed Pharmaceuticals's operating cash flow per share for the three months ended in Mar. 2025 was $-0.66. Galmed Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was $-19.20.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 70.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 46.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Galmed Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

GLMD' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -65.1 Med: -1.9 Max: 70.3
Current: 70.3

During the past 13 years, Galmed Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 70.30% per year. The lowest was -65.10% per year. And the median was -1.90% per year.

GLMD's 3-Year OCF Growth Rate is ranked better than
94.91% of 1217 companies
in the Biotechnology industry
Industry Median: 9.3 vs GLMD: 70.30

Galmed Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Galmed Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galmed Pharmaceuticals Operating Cash Flow per Share Chart

Galmed Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-222.77

-240.09

-132.15

-26.57

-6.32

Galmed Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-3.01	-1.94	-15.42	-1.18	-0.66

Competitive Comparison of Galmed Pharmaceuticals's Operating Cash Flow per Share

For the Biotechnology subindustry, Galmed Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galmed Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Galmed Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Galmed Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-5.88	/	0.931
	=	-6.32

Galmed Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-1.167	/	1.780
	=	-0.66

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.20

Galmed Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Galmed Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Galmed Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galmed Pharmaceuticals Ltd (NAS:GLMD) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Abba Hillel Road, Ramat Gan, ISR, 5250608

Website

https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.